chartexchange

BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences

Newsfile | Sep 21, 2026 8:30 AM EDT

Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy technologies focused on the early detection of lung cancer through metabolomics, is pleased to announce today its participation in two upcoming life sciences events in Quebec during the week of October 4, 2026.The Company will participate in the 16th Annual Mass Spectrometry & Advances in the Clinical...

Read original article